Latest News

Seizing Hope: UCB’s Advances in Epilepsy and Rare Syndromes
Seizing Hope: UCB’s Advances in Epilepsy and Rare Syndromes

December 12th 2024

Hugo Xi, head of Medical Neurology at UCB, discussed the company’s groundbreaking research, innovations in epilepsy care, and the company’s commitment to advancing treatments for rare syndromes at the 2024 AES Annual Meeting.

Rob Etherington  (Credit: Clene)
Clene Receives FDA Guidance on Accelerated Approval Pathway for CNM-Au8 in ALS, Plans Further Biomarker Analysis

December 12th 2024

Widen the Window, Close the Gap: Revolutionizing Stroke Care in Alaska
Widen the Window, Close the Gap: Revolutionizing Stroke Care in Alaska

December 12th 2024

Walid Abi-Saab, MD  (Credit: uniQure)
FDA Reaches Alignment on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington Disease

December 12th 2024

Primal Kaur, MD, MBA  (Credit: LinkedIn)
Tavapadon Meets Primary and Secondary End Points in Phase 3 TEMPO-2 Trial for Early Parkinson Disease

December 11th 2024

Coverage of the American Epilepsy Society Annual Meeting

Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in Los Angeles.

MDS 2024

Conference Coverage

View All
Seizing Hope: UCB’s Advances in Epilepsy and Rare Syndromes
Seizing Hope: UCB’s Advances in Epilepsy and Rare Syndromes

December 12th 2024

NeuroVoices: Alexander C. Whiting, MD, on Advancing Epilepsy Surgery and Brain Function Research
NeuroVoices: Alexander C. Whiting, MD, on Advancing Epilepsy Surgery and Brain Function Research

December 11th 2024

Promise Behind Stem Cell Approaches to Treat Epilepsy: Jonathan Parker, MD, PhD
Promise Behind Stem Cell Approaches to Treat Epilepsy: Jonathan Parker, MD, PhD

December 10th 2024

Soticlestat Improves Caregiver and Clinical Measures in ENDYMION 2 Trial of Dravet Syndrome and LGS
Soticlestat Improves Caregiver and Clinical Measures in ENDYMION 2 Trial of Dravet Syndrome and LGS

December 10th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.